Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JD.1.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.43ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.43NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JC.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JC.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JC.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16719.1US
XDPORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDPENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDPNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
KP.3.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LB.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LB.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used